An international audience was at the Bush Library participating in the formal announcement selling a pharmaceutical company founded by the Texas A&M System to investors from Japan.
What was known as Kalon Biotherapeutics is now FDB, which is short for FUJIFILM Diosynth Biotechnologies.
FDB purchased a 49 percent interest with the option of acquiring the rest of Kalon.
Negotiations began 15 months ago, then were finalized during an 11 day period that ended Thursday with a program in the library auditorium featuring nine speakers, followed by a ceremonial signing in the library rotunda.
Click HERE for more information from FUJIFILM Diosynth Biotechnologies.
Click below to listen to speakers in order of appearance.
Texas A&M System Chancellor John Sharp
Texas A&M Health Science Center President Dr. Brett Giroir
Kalon Biotherapeutics Board Chairman and A&M System Board of Regents member John White
Japan Consul General Nozomu Takaoka
FUJIFILM Holdings Corporation President/COO Shigehiro Nakajima
Mitsubishi Executive VP/Regional CEO North America Yasuyuki Sugiura